QA: Dare Bioscience Inc. in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001401914_2023_Dare_Bioscience_Inc.pdf

Logs

Graph

Absolute values for 0001401914, Dare Bioscience Inc.

  xvar xval
0 AssetsCurrent 43,038,753
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 64,908
3 remainder_Assets 722,722
4 LiabilitiesCurrent 31,623,927
5 LiabilitiesNoncurrent 1,090,346
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 11,243,271
9 ResearchAndDevelopmentExpense 30,042,217
10 remainder_Expenses 100,000
11 remainder_Revenues 10,000,000
12 remainder_NetIncome 437,750
13 remainder_ComprehensiveNetIncome -196,338
  yvar yval
0 Assets 43,826,383
1 Liabilities 32,714,273
2 Expenses 41,385,488
3 Revenues 10,000,000
4 StockholdersEquity 11,112,110
5 NetIncome -30,947,738
6 ComprehensiveNetIncome -31,045,907
7 BaseVar 64,280,116
8 EconomicCapitalRatio -0.312

Edgar->Model Mapping

Feature Distribution

Change over Time